Ipsen Biopharmaceuticals, Inc. is the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), a global biopharmaceutical group focused on innovation and specialty care. The company is dedicated to providing hope for patients whose lives are challenged by difficult-to-treat diseases. For more information please visit www.ipsenus.com.